Telesis Bio (TBIO) Competitors $1.37 +0.01 (+0.74%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends TBIO vs. PRPO, TLIS, SPEC, THMO, OLITW, PRENW, QSIAW, SMAPW, CHRS, and CGENShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Precipio (PRPO), Talis Biomedical (TLIS), Spectaire (SPEC), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Coherus BioSciences (CHRS), and Compugen (CGEN). Telesis Bio vs. Precipio Talis Biomedical Spectaire ThermoGenesis OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Coherus BioSciences Compugen Precipio (NASDAQ:PRPO) and Telesis Bio (NASDAQ:TBIO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability, earnings and community ranking. Does the media prefer PRPO or TBIO? In the previous week, Precipio's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score. Company Overall Sentiment Precipio Neutral Telesis Bio Neutral Do analysts rate PRPO or TBIO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ATelesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is PRPO or TBIO more profitable? Precipio has a net margin of -22.90% compared to Telesis Bio's net margin of -282.58%. Precipio's return on equity of -39.66% beat Telesis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Precipio-22.90% -39.66% -29.19% Telesis Bio -282.58%-359.32%-50.95% Does the MarketBeat Community prefer PRPO or TBIO? Precipio received 263 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote. CompanyUnderperformOutperformPrecipioOutperform Votes27273.32% Underperform Votes9926.68% Telesis BioOutperform Votes952.94% Underperform Votes847.06% Which has more risk & volatility, PRPO or TBIO? Precipio has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.87, suggesting that its stock price is 87% more volatile than the S&P 500. Which has stronger valuation and earnings, PRPO or TBIO? Precipio has higher earnings, but lower revenue than Telesis Bio. Precipio is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecipio$15.20M0.61-$5.85M-$2.45-2.57Telesis Bio$225.09M0.01-$47.72M-$30.77-0.04 Do insiders & institutionals believe in PRPO or TBIO? 10.5% of Precipio shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 13.3% of Precipio shares are held by company insiders. Comparatively, 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryPrecipio beats Telesis Bio on 8 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.43M$5.79B$5.39B$8.53BDividend YieldN/A0.43%5.13%4.14%P/E Ratio-0.0418.91113.8115.12Price / Sales0.013.971,483.2593.03Price / CashN/A37.9439.6434.05Price / Book9.792.624.665.02Net Income-$47.72M$515,312.50$119.06M$225.46M7 Day Performance-9.87%4.03%0.79%0.37%1 Month Performance-56.78%-2.54%5.65%3.57%1 Year Performance-89.99%-9.85%36.76%29.42% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$1.37+0.7%N/A-89.6%$2.43M$225.09M-0.04200Gap UpPRPOPrecipio0.7609 of 5 stars$6.35+1.4%N/A-17.6%$9.40M$15.20M-2.5960Positive NewsTLISTalis BiomedicalN/A$1.75+5.4%N/A-65.7%$3.19M$300,000.00-0.06260News CoverageSPECSpectaireN/A$0.05-4.6%$2.50+5,141.1%-98.5%$878,000.00N/A0.008Gap DownTHMOThermoGenesisN/A$0.00flat$5.00+833,233.3%-99.9%$5,000.00$9.61M0.0025Gap DownOLITWOmniLit AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01flatN/A-26.1%$0.00$22.66M0.001Positive NewsQSIAWQuantum-SiN/A$0.06-7.6%N/A-40.7%$0.00$1.70M0.00159Gap DownHigh Trading VolumeSMAPWSportsMap Tech AcquisitionN/A$0.03-24.2%N/A-21.2%$0.00N/A0.00N/AGap DownHigh Trading VolumeCHRSCoherus BioSciences3.8143 of 5 stars$0.75+1.4%$7.13+845.2%-77.4%$86.48M$308.13M-1.88246Upcoming EarningsCGENCompugen2.1732 of 5 stars$1.63-2.7%$4.00+146.2%+125.0%$145.01M$42.72M-16.2568Upcoming EarningsPositive News Related Companies and Tools Related Companies Precipio Competitors Talis Biomedical Competitors Spectaire Competitors ThermoGenesis Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Coherus BioSciences Competitors Compugen Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TBIO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
